Consultant in Endocrinology at Mayo Clinic
Endocrinology
Dr. Rebecca S. Bahn, MD
|
|
Give Review
Rebecca S. Bahn, MD works in the field of Endocrinology. He attended Mayo Medical School. Mayo Medical School is ranked 27 in research and 42 in primary care medicine Rebecca Bahn is also a published MD. He has 100 publication published. The most recent publication is: Immunodetection of manganese superoxide dismutase in cultured human retroocular fibroblasts using sera directed against the thyrotropin receptor. Rebecca Bahn accepts Medicare payments and is listed with Medicare.gov.
Publications
- Development and Pilot Testing of an Encounter Tool for Shared Decision Making About the Treatment of Graves' Disease.
- Randomized controlled trial of rituximab in patients with Graves' orbitopathy.
- Mentoring Interdisciplinary Research Teams for the Study of Sex and Gender Differences in Health and Disease.
- News and views: at long last, an animal model of graves' orbitopathy.
- Comparative effectiveness of therapies for graves' hyperthyroidism: a systematic review and network meta-analysis.
- Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease - Clinical Presentation and Response to Therapy.
- Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart Disease-A cohort study.
- A Small Molecule Antagonist Inhibits Thyrotropin Receptor Antibody-Induced Orbital Fibroblast Functions Involved in the Pathogenesis of Graves Ophthalmopathy.
- Bioidentical compounded hormones: A pharmacokinetic evaluation in a randomized clinical trial.
- Cohort Study on Radioactive Iodine-induced Hypothyroidism - Implications for Graves' Ophthalmopathy and Optimal Timing for Thyroid Hormone Assessment.
- Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.
- A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart Disease.
- Autoimmunity and graves' Disease.
- Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
- Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
- Approach to the patient with nontoxic multinodular Goiter.
- Relationships between thyroid function and lipid status or insulin resistance in a pediatric population.
- Risk factors for development or deterioration of Graves' ophthalmopathy.
- Graves' ophthalmopathy.
- A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.
- Development and application of magnetic resonance elastography of the normal and pathological thyroid gland in vivo.
- The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and...
- Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
- Principles to promote physician satisfaction and work-life balance.
- How perceived physician leadership behavior affects physician satisfaction.
- Thyroid societies across the world.
- Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
- Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.
- Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy.
- Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment.
- The impact of overt and subclinical hyperthyroidism on skeletal muscle.
- Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adip...
- Thyroid transcription factor-1 in orbital adipose tissues: potential role in orbital thyrotropin receptor expression.
- Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.
- Effects of reducing the upper limit of normal TSH values.
- Current perspective on the pathogenesis of Graves' Disease and ophthalmopathy.
- Optic neuropathy of Graves Disease: results of transantral orbital decompression and long-term follow-up in 215 patients.
- Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy.
- Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of Disease.
- Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy.
- The aftermath of orbital radiotherapy for graves' ophthalmopathy.
- Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte ...
- Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
- The possible contribution of anti-Gal to Graves' Disease.
- The EUGOGO consensus statement on the management of Graves' orbitopathy: equally applicable to North American clinicians and patients.
- Graves' Disease.
- High-dose intravenous glucocorticoid therapy for Graves' ophthalmopathy: where are we now?
- Influence of the TSH receptor gene on susceptibility to Graves' Disease and Graves' ophthalmopathy.
- Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
- Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
- A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
- Induction of leptin expression in orbital preadipocyte fibroblasts.
- Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital pr...
- Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune Disease?
- Relationship between Disease duration and predominant orbital T cell subset in Graves' ophthalmopathy.
- Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor.
- Oxygen free radicals in interleukin-1beta-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients.
- Immunodetection of manganese superoxide dismutase in cultured human retroocular fibroblasts using sera directed against the thyrotropin receptor.
- Cytokines in thyroid eye Disease: potential for anticytokine therapy.
- Cytokines in the evolution of Graves'' ophthalmopathy.
- Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin.
- Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
- Thyrotropin receptor expression in adrenal, kidney, and thymus.
- Superoxide radical production stimulates retroocular fibroblast proliferation in Graves'' ophthalmopathy.
- Molecular analysis of antigen receptor variable region repertoires in T lymphocytes infiltrating the intrathyroidal and extrathyroidal manifestations in patients with ...
- Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' Disease in a North American Caucasian population.
- Management of thyroid nodules in pregnancy.
- Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' Disease.
- Tissue eosinophilia and eosinophil degranulation in Riedel's invasive fibrous Thyroiditis.
- Lack of an independent association between the human leukocyte antigen allele DQA1*0501 and Graves' Disease.
- Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patient...
- [Detection, localization and modulation of hyaluronic acid/CD44 receptor expression in patients with endocrine orbitopathy].
- Glucocorticoids modulate the synthesis and expression of a 72 kDa heat shock protein in cultured Graves'' retroocular fibroblasts.
- Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves'' ophthalmopathy.
- Pathogenesis of Graves' ophthalmopathy.
- Orbital connective tissue in endocrine ophthalmopathy.
- The enigma of Graves' ophthalmopathy.
- Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists.
- Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy.
- Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves'' ophthalmopathy and thyroid Diseases.
- Analysis of retroorbital T cell antigen receptor variable region gene usage in patients with Graves'' ophthalmopathy.
- The fibroblast is the target cell in the connective tissue manifestations of Graves'' Disease.
- Modulation of cellular functions in retroorbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene.
- Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves'' ophthalmop...
- Analysis of T-cell antigen receptor variable region gene usage in patients with thyroid-related pretibial dermopathy.
- Nongoitrous (type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo.
- A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid Disease in females.
- Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy.
- A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy.
- Normal function in vivo of a homozygotic polymorphism in the human thyrotropin receptor.
- Characterization of steroid production in cultured human choriocarcinoma cells.
- Epidermal growth factor stimulates production of progesterone in cultured human choriocarcinoma cells.
- Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy.
- Amplification of RNA and DNA specific for erb B in unbalanced 1;7 chromosomal translocation associated with myelodysplastic syndrome.
- Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy.
- Diagnostic evaluation of Graves' ophthalmopathy.
- Nonidentical expressions of multiple endocrine neoplasia, type I, in identical twins.
- Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts.
- Presence of antibodies in the sera of patients with Graves' Disease recognizing a 23 kilodalton fibroblast protein.
Schools
Mayo Medical School
Mayo Grad School Med
Conditions Treated
- Goiter
- Hashimoto's Disease
- Osteoporosis
- Thyroiditis
Doctors Specialties
- Endocrinology
Accepted Insurances
- Choice Plus POS II
- Great West Healthcare-Cigna PPO
- Choice Plus POS
- Options PPO
Education
-
Mayo School of Graduate Medical Education -
Mayo Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1326019936 | |
| NPPES Provider LastName | BAHN | |
| NPPES Provider FirstName | REBECCA | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326019936 |
| Last Name Of The Provider | BAHN |
| First Name Of The Provider | REBECCA |
| View All |
Similar Doctors
|
|
Dr. Maria L. Collazo-Clavell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael R. Nannenga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah Nadeem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Byron L. Riggs Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diana S. Dean, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kurt A. Kennel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Wermers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dana Erickson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul C. Carpenter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel L. Hurley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen F. Hodgson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan A. Harker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mabel M. Ryder, MD
This Doctor is OpenDoctor Recommended.
|